4//SEC Filing
Meckler Jeffrey A 4
Accession 0001641172-25-003824
CIK 0001857044other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:15 PM ET
Size
16.4 KB
Accession
0001641172-25-003824
Insider Transaction Report
Form 4
Meckler Jeffrey A
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.04/sh−4,750$176→ 0 totalExercise: $536.00From: 2017-12-11Exp: 2027-12-11→ Common Stock (4,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.04/sh−813$30→ 0 totalExercise: $425.60From: 2017-05-01Exp: 2027-05-01→ Common Stock (813 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.04/sh−1,563$58→ 0 totalExercise: $611.20From: 2019-04-04Exp: 2026-04-04→ Common Stock (1,563 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.04/sh−1,250$46→ 0 totalExercise: $355.20From: 2018-06-28Exp: 2025-06-28→ Common Stock (1,250 underlying) - Disposition to Issuer
sStock Option (right to buy)
2025-04-10$0.04/sh−1,500$56→ 0 totalExercise: $425.60From: 2017-04-10Exp: 2027-04-10→ Common Stock (1,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.04/sh−3,750$139→ 0 totalExercise: $24.60From: 2020-07-15Exp: 2027-07-15→ Common Stock (3,750 underlying)
Footnotes (1)
- [F1]The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001506916
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:15 PM ET
- Size
- 16.4 KB